Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
Envista Hldg Rg (NY Consolidated)
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (USD)
28,97 0,70 0,20 43 161 475
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiEnvista Holdings Corp
TickerNVST
Kmenové akcie:Ordinary Shares
RICNVST.K
ISIN-
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.12.2025
Počet zaměstnanců k 31.12.2024 12 300
Akcie v oběhu k 31.12.2025 163 800 000
MěnaUSD
Konstituent indexůS&P 400 Mid Cap
Kontaktní informace
Ulice200 S. Kraemer Blvd., Bldg. E
MěstoBREA
PSČ92821
ZeměUnited States
Kontatní osobaJim Gustafson
Funkce kontaktní osobyVice President - Investor Relations
Telefon17 148 175 418
Fax13026555049

Business Summary: Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Envista Holdings Corp revenues increased 8% to $2.72B. Net income totaled $47M vs. loss of $1.12B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Interest expense, net decrease of 21% to $36.6M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$6.50 to $0.28.
Odvětvová klasifikace
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSDental Equipment and Supplies Manufacturing
NAICSSoftware Publishers
NAICS2007Dental Equipment & Supplies Mfg
NAICS2007Software Publishers
NAICS1997Dental Equipment and Supplies Manufacturing
NAICS1997Software Publishers
SICDental Equipment And Supplies
SICPrepackaged Software



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorPaul Keel5501.05.202401.05.2024
Chief Financial Officer, Senior Vice PresidentEric Hammes5001.08.202401.08.2024
President - OrthodonticsVeronica Acurio5502.08.202402.08.2024
President - DiagnosticsRobert Befidi51
President - Nobel BiocareStefan Nilsson5515.07.202415.07.2024
Senior Vice President, General Counsel, SecretaryMark Nance57
Senior Vice President - Strategy and Corporate DevelopmentMischa Reis53